M&A Deal Summary

Isracann Acquires Praesidio Health

On February 22, 2022, Isracann acquired life science company Praesidio Health

Acquisition Highlights
  • This is Isracann’s 1st transaction in the Life Science sector.
  • This is Isracann’s 1st transaction in Canada.
  • This is Isracann’s 1st transaction in British Columbia.

M&A Deal Summary
Date 2022-02-22
Target Praesidio Health
Sector Life Science
Buyer(s) Isracann
Deal Type Add-on Acquisition

Target

Praesidio Health

Abbotsford, British Columbia, Canada
Praesidio Health is a medical research company that develops and validates natural health medicine (NHM) using an evidence-based process. Pioneering NHMs and therapeutics, Praesidio Health is actively developing several product candidates for utility in a range of conditions, including post-viral exposure prophylaxis, urological, anxiety/stress, immune booster, and sleep aids. Praesidio Health is based in Abbotsford, British Columbia.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Isracann

Vancouver, British Columbia, Canada
Category Company
Founded 2010
Sector Information Technology
Revenue 3M CAD (2022)
DESCRIPTION

Isracann validates transactions on the blockchain. Isracann provides co-location, back-up/redundancy IT, telecom equipment, and cloud computing services to small and medium-size businesses in Western Canada. Isracann was founded in 2010 and is based in Vancouver, British Columbia.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (British Columbia) 1 of 1
Country (Canada) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal